Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of 68 Ga 3+ , 111 In 3+ , 177 Lu 3+ and 225 Ac 3+
- 1 December 2017
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 55, 38-46
Abstract
No abstract availableKeywords
Funding Information
- Weill Cornell
This publication has 52 references indexed in Scilit:
- Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate CancerJournal of Nuclear Medicine, 2016
- Design of Internalizing PSMA-specific Glu-ureido-based RadiotherapeuticalsTheranostics, 2016
- 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate CancerJournal of Nuclear Medicine, 2013
- 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET ImagingBioconjugate Chemistry, 2012
- 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In VivoJournal of Nuclear Medicine, 2010
- 68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate CancerJournal of Medicinal Chemistry, 2010
- Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate CancerCancer Research, 2009
- Pilot Trial of Unlabeled and Indium-111–Labeled Anti–Prostate-Specific Membrane Antigen Antibody J591 for Castrate Metastatic Prostate CancerClinical Cancer Research, 2005
- Radioimmunotherapy of Prostate Cancer Using 90Y- and 177Lu-Labeled J591 Monoclonal Antibodies: Effect of Multiple Treatments on MyelotoxicityClinical Cancer Research, 2005
- Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen:In vivoImaging in Experimental Models of Prostate CancerClinical Cancer Research, 2005